Diabetes News Archive
Artificial intelligence software that can detect diabetic retinopathy has been approved by the U.S. Food and Drug Administration.
Benefits seen in markers of cardiometabolic disease, including insulin sensitivity
ACP responds to criticism from the ADA, the Endocrine Society, the AACE, and the AADE of guidance that clinicians should aim to achieve an HbA1c level between 7% and 8% in most people with type 2 diabetes.
A diabetes transition registry may help adolescents with type 1 diabetes plan and prepare for independent adult care.
Better glycemic control, weight reduction with surgical treatment for youths with T2D, severe obesity
For adolescents with type 2 diabetes and severe obesity, surgical therapy facilitates glycemic control and weight reduction better than medical therapy.
A high fiber diet promotes gut bacteria that helps blood glucose control in patients with type 2 diabetes.
The American College of Physicians has developed recommendation statements to guide clinicians in selecting targets for pharmacologic treatment of type 2 diabetes.
HbA1C, diabetes status, and cognitive decline during a span of 10 years were compared using data from the English Longitudinal Study of Ageing.
The ADA's updates include a modified patient-focused care algorithm as well as improved risk management for CVD.
The FDA has approved the Dermapace System for treatment of chronic, full-thickness diabetic foot ulcers.
The new FDA approved short-acting insulin drug can be used to treat T1 and T2 diabetes.
With the help of a doctor and a weight loss plan, new research suggests type 2 diabetes can be reversed in less than a year.
The FDA has approved semaglutide injection as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Oral insulin usage does not prevent the development of type 1 diabetes in relatives of patients.
Primary care referral to Weight Watchers meetings is associated with weight loss, HbA1c reduction.
Statins are associated with an increased risk for developing type 2 diabetes, especially for high-risk individuals.
With a little creativity, children with diabetes can enjoy the festivities of Halloween.
Type 2 diabetes risk is increased in young adults through antidepressant use, specifically the duration of use and the cumulative dose.
Type 2 diabetes is greater with second-generation antipsychotics than with non-second-generation antipsychotic psychotropic medications for patients aged 6 to 25 years.
Insulin pump therapy is linked to lower risks of severe hypoglycemia and diabetic ketoacidosis and better glycemic control than insulin injection therapy.
The system uses a small sensor implanted below the skin and a mobile reader to continuously monitor blood glucose.
After the inclusion of recent negative studies, a statistically significant association between AD use and diabetes was observed.
The 12-year results show that Roux-en-Y gastric bypass offered long-term durability of weight loss and was associated with fewer obesity-related coexisting conditions compared with those who did not have the surgery.
The statement includes advances in care since the ADA's last position statement was published in 2003.
Sleep duration for 1 hour longer was associated with lower BMI, fat mass, insulin resistance, and fasting glucose but had no effect on HbA1c or cardiovascular risk.
Lifestyle interventions maintain glycemic control in patients with type 2 diabetes.
Consumption of alcohol 3 to 4 days weekly is associated with a significantly lower risk for diabetes in men and women.
Lifestyle interventions reduce gestational weight gain across various subgroups of women and lower the odds of cesarean section without affecting offspring outcomes.
HIV-infected patients on ART had approximately 4 and 1.5 greater odds of developing diabetes mellitus and metabolic syndrome, respectively.
Degludec is noninferior to glargine regarding the incidence of major cardiovascular events among patients with type 2 diabetes.
Almost half of participants reported that they never received information regarding the side effects of their medication from their prescriber.
The score can predict the effectiveness of weight-loss therapy for preventing diabetes in overweight or obese individuals.
Patients exhibiting moderate-to-severe depressive symptoms had worse adherence than nondepressed patients.
Women who took probiotics in their second trimester had lower rates of gestational diabetes.
A study of one tracking system's effect finds improvement in the management of diabetes.
Patients taking linagliptin had decreased HbA1c as well as reactive oxygen species generation and plasma lipid peroxide levels.
Adolescents with type 2 diabetes decreased HbA1c levels after using insulin pump therapy for a 3-month period.
Diabetes incidence rates in the US and glucose intolerance worldwide increased per 1°C increase in temperature.
The Stepping Up model of care produced a clinically and significantly significant improvement in HbA1c among adults with type 2 diabetes managed in primary care.
Individuals who consume the least amount of gluten are more likely to develop type 2 diabetes.
Vildagliptin lowers blood pressure and elevates heart rate, while metformin increases heart rate with no effect on blood pressure.
The position statement by the ADA incorporates updates in treatment and screening for patients with diabetic retinopathy.
Depression is common in patients receiving chronic hemodialysis but seems to be ineffectively treated.
Researchers observed a reduced risk of all-cause mortality and CVD with dapagliflozin and a lower risk of mortality with dipeptidyl-peptidase-4 inhibitors.
Diabetes without insulin did not appear to increase thromboembolic risk in patients with atrial fibrillation treated with anticoagulation.
The document addresses important new issues in diabetes management, including metabolic surgery and a more specific definition of hypoglycemia.
Prediabetes does not always show clear symptoms; however, it can lead to type 2 diabetes, heart disease, or stroke.
Among all women, PPD risk increased with advanced age and gestational diabetes.
Fasting glucose is specific but not sensitive, and HbA1c is neither sensitive nor specific.
Researchers observed a high efficacy rate for both glyburide and metformin.
Men with diabetes, but not women, had excess mortality risk associated with depression and anxiety.
The most frequent enterovirus types included coxsackievirus A4, coxsackievirus A2, and coxsackievirus A16.
The study suggests that neither fish oil nor aspirin can be recommended for the prevention of AVF failure.
The ACP has updated the 2012 guideline to provide clinical recommendations of oral pharmacologic treatment of type 2 diabetes.
The FDA has approved a continuous glucose monitoring system to replace fingerstick blood sugar testing in patients with diabetes.
Higher ambulatory volume was linked to lower quality of care and quality increased with higher diabetes-specific volume.
The position statement provides recommendations for psychosocial assessment and care of individuals with diabetes.
Risk was dependent on dose, background medications, and type of GLP-1 receptor agonist.
The continuous glucose monitoring system detected 81% of hypoglycemic events within 30 minutes.
Often underreported and undertreated, outcomes can be improved in this condition with appropriate screening and diagnosis.
Combining FFR with imaging techniques may be required to guide the treatment strategy in patients with high-risk, fast-progressing atherosclerosis.
The ADA releases its first independent recommendations on physical activity and exercise for all patients with diabetes.
Hepatic and peripheral insulin sensitivity in patients with type 2 diabetes were not affected by resveratrol treatment.
Researchers observed significant improvement in LDL cholesterol in those at risk for diabetes.
Individuals with prediabetes may reduce their risk of diabetes with stepwise diabetes prevention.
A target intake of at least 500 mg/d is recommended to combat sight-threatening diabetic retinopathy.
Canagliflozin 100 mg or 300 mg slowed kidney decline compared with glimepiride.
Patients with type 2 diabetes with systolic blood pressure lower than 140 mm Hg have a lower risk of cardiovascular events.
The once-daily injection works to improve glycemic control.
Patients with prediabetes who briskly walked saw greater improvements in oral glucose tolerance compared with those who jogged.
A meta-analysis of the 9 classes of glucose-lowering drugs supports the ADA's recommendation of metformin monotherapy as preferred initial treatment.
Readmission was more common among publically insured, black patients presenting with comorbidities including hypertension and diabetes.
Reductions in disease risk were observed for an intake as high as 7.5 servings of whole grains per day.
Coronary artery bypass surgery may lead to metabolic changes, causing new-onset diabetes.
Use of the Glucommander was linked to a shorter time to achieving blood glucose levels lower than 200 mg/dL.
New guidelines support use of metabolic surgery as standard treatment option for type 2 diabetes, obesity
A panel of experts has recommended that metabolic surgery be included as a treatment option for patients with type 2 diabetes and obesity.
Glucocorticoid therapy in patients with rheumatoid arthritis has been linked to elevated risk of diabetes.
Pediatric patients with type 1 diabetes often have low levels of vitamin D.
Women who had gestational diabetes may be able to reduce their risk of developing hypertension by eating a healthy diet.
Metformin more effective than sulfonylureas for reducing cardiovascular mortality in diabetes patients
Compared with other drugs for type 2 diabetes, metformin is superior for reducing the risk of cardiovascular mortality.
The FDA will add warnings about heart failure risk to the labels of type 2 diabetes medicines containing saxagliptin and alogliptin.
From 1980 to 2014, the number of people worldwide with diabetes has increased from 108 million to 422 million.
Regardless of history of heart failure, incretin-based medications are not associated with an increased risk for hospitalization due to heart failure.
High body fat percentage and low BMI are associated with increased mortality in women and men.
Treatment guidelines must expand to focus on patients co-infected with both HCV and HIV.
Very few patients with glycated hemoglobin levels that indicate prediabetes are being told they have the condition.
High body weight percentage may increase mortality, and poor physical fitness in youth can increase diabetes risk later in life.
The CPAP group had a larger decrease in HbA1c levels after 6 months.
The ADA has published the 2016 Standards of Medical Care in Diabetes that outline the best practices for diabetes care and management.
Once-weekly GLP-1RAs reduced HbA1c and fasting plasma glucose.
Renin angiotensin system blockers have similar risks and outcomes compared with other antihypertensive agents for patients with diabetes.
Eating more potatoes before pregnancy may be associated with greater risk of gestational diabetes mellitus,
A statin plus extended-release niacin reduces apoB-48 concentrations in patients with type 2 diabetes, compared with a statin alone.
Premature birth has been associated with a number of adverse health conditions.
Intranasal glucagon is noninferior to intramuscular glucagon in adults with type 1 diabetes.
More than 60% of the 31,545 patients analyzed between 2001 and 2013 underwent HbA1c at least four times per year.
Research shows that adding metformin to insulin therapy will not boost glycemic control in overweight teens with type 1 diabetes.
Breastfeeding for 2 or more months may reduce the odds of developing type 2 diabetes in mothers previously diagnosed with gestational diabetes.
Three renal biomarkers - AKI, albuminuria, and eGFR - can predict adverse outcomes in diabetes, according to a study published in Diabetes Care.
In adolescents with type 1 or type 2 diabetes, the rates of diagnosed depression are lower than the number of patients reporting depressive symptoms.